Bioquell lifts H1 profit, restructures management

Bioquell has booked a first-half pre-tax profit of £378,000, from a profit of £69,000. Revenue slipped to £12.1m, from £12.5m. It cited cost reduction for the improved profitability as it implemented several management changes.

It said, following a strategic review, that shareholders' interests would best be served by continuing to build a world class bio-decontamination business and focusing on further improving its financial performance.

Management of the business would be restructured.

Non-executive chairman Ian Johnson had become executive chairman. Chief executive Nick Adams had stepped down. Jay LeCoque had joined the board in the new role of commercial director.